Non-alcoholic Fatty Liver Disease
16 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Berberine ursodeoxycholate for non-alcoholic fatty liver disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| DR10624 Injection for non-alcoholic fatty liver disease | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ECC0509 for non-alcoholic fatty liver disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ECC0509 + ECC4703 for non-alcoholic fatty liver disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ECC4703 for non-alcoholic fatty liver disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Efruxifermin for non-alcoholic fatty liver disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Empagliflozin for non-alcoholic fatty liver disease | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Food Security Screening & Referral Program for non-alcoholic fatty liver disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HSK31679 for non-alcoholic fatty liver disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HU6 for non-alcoholic fatty liver disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Pegargiminase for non-alcoholic fatty liver disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PolyPill for non-alcoholic fatty liver disease | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Semaglutide for non-alcoholic fatty liver disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| SNP-610 for non-alcoholic fatty liver disease | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Standard Soy Milk for non-alcoholic fatty liver disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Survodutide for non-alcoholic fatty liver disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |